

Microarray analysis of mononuclears transcriptome of lung cancer patients
https://doi.org/10.25557/2073-7998.2022.07.33-35
Abstract
About the Authors
V. Yu. BuslaevRussian Federation
V. I. Minina
Russian Federation
V. G. Druzhinin
Russian Federation
References
1. Bray F., Ferlay J., Soerjomataram I., et al. Global cancerstatistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. 2018 Nov;68(6):394-424.
2. Malhotra J., Malvezzi M., Negri E., et al. Risk factors for lung cancer worldwide. Eur Respir J. 2016 Sep;48(3):889-902.
3. Wang J., Liu Q., Yuan S., et al. Genetic predisposition to lung cancer: comprehensive literature integration, meta-analysis, and multiple evidence assessment of candidate-gene association studies. Sci Rep. 2017 Aug;7(1):8371-8384.
4. Han J., Chen M., Wang Y., et al. Identification of Biomarkers Based on Differentially Expressed Genes in Papillary Thyroid Carcinoma. Sci Rep. 2018 Jul;8(1):9912-9923.
5. Malone J.H., Oliver B. Microarrays, deep sequencing and the true measure of the transcriptome. BMC Biol. 2011 May;9(1):34-43.
6. Misono S., Mizuno K., Suetsugu T., et al. Molecular Signature of Small Cell Lung Cancer after Treatment Failure: The MCM Complex as Therapeutic Target. Cancers. 2021 Mar 10;13(6):1187-1203.
Review
For citations:
Buslaev V.Yu., Minina V.I., Druzhinin V.G. Microarray analysis of mononuclears transcriptome of lung cancer patients. Medical Genetics. 2022;21(7):33-35. (In Russ.) https://doi.org/10.25557/2073-7998.2022.07.33-35